VIRGINIA LAW PORTAL

• Code of Virginia
• Virginia Administrative Code
• Constitution of Virginia
• Charters
• Authorities
• Compacts
• Uncodified Acts
• RIS Users (account required)

SEARCHABLE DATABASES

• Bills & Resolutions
  session legislation
• Bill Summaries
  session summaries
• Reports to the General Assembly
  House and Senate documents
• Legislative Liaisons
  State agency contacts

ACROSS SESSIONS

• Subject Index: Since 1995
• Bills & Resolutions: Since 1994
• Summaries: Since 1994

Developed and maintained by the Division of Legislative Automated Systems.

2012 SESSION

• | print version

SB 450 Chemotherapy; requirements for orally administered cancer drugs.

Introduced by: Jill Holtzman Vogel | all patrons    ...    notes | add to my profiles | history

SUMMARY AS PASSED:

Health insurance; parity of coverage for oral chemotherapy medications.  Provides that each health insurer, health care subscription plan, and health maintenance organization whose policies, contracts, or plans include coverage for intravenously administered, injected, and orally administered anticancer drugs shall provide that the criteria for establishing cost sharing applicable to orally administered cancer chemotherapy drugs and cancer chemotherapy drugs that are administered intravenously or by injection shall be consistently applied within the same plan. This requirement will apply to the state employees' health insurance plan and to the local choice health program. This bill is identical to HB 1273.

SUMMARY AS INTRODUCED:

Health insurance; parity of coverage for oral chemotherapy medications.  Requires health insurers, health care subscription plans, and health maintenance organizations whose policies provide coverage for cancer chemotherapy treatment to provide coverage for a prescribed, orally administered anticancer medication on a basis no less favorable than that on which it provides coverage for intravenously administered or injected anticancer medications. Such a policy, contract, or plan shall not require a higher copayment, deductible, or coinsurance amount for a prescribed, orally administered anticancer medication than what it requires for an intravenously administered or injected anticancer medication that is provided, regardless of formulation or benefit category determination by the insurer, corporation, or health maintenance organization. The mandate will apply to the state employees' health insurance plan and to the local choice health program.